GlassScriptPhysician profile
John W Verbsky
NPI 1760693873
$8,004.65
in general payments reported to CMS, 2019-2025
18 companies · $1,005 in 2025
The $1,005 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,099 · 2020: $1,399 · 2021: $285 · 2022: $985 · 2023: $1,590 · 2024: $1,643 · 2025: $1,005.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,237.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $3,199.96 | 2022-2025 | Biomonitor, Rivacor 7 Dr-T, Amvia Edge |
| Boston Scientific Corporation | $1,911.50 | 2019-2023 | Watchman Flx |
| Biosense Webster, INC. | $1,165.25 | 2019-2025 | Carto 3, Octaray Mapping Catheter |
| Atricure, INC. | $886.44 | 2020-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $218.69 | 2020-2021 | |
| Amgen INC. | $172.57 | 2019-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $132.46 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $107.80 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $36.56 | 2025 | Eliquis |
| Amarin Pharma, INC. | $27.15 | 2019 | |
| Medtronic Vascular, INC. | $23.39 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.32 | 2019-2020 | |
| Chiesi USA, INC. | $20.13 | 2023 | Kengreal |
| Abiomed | $19.16 | 2023 | Impella |
| Merck Sharp & Dohme LLC | $17.82 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15.24 | 2023 | Micra |
| Philips North America LLC | $13.73 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Verbsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.